Literature DB >> 17292827

Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.

Jian-Hua Mao1, Di Wu, Jesus Perez-Losada, Tao Jiang, Qian Li, Richard M Neve, Joe W Gray, Wei-Wen Cai, Allan Balmain.   

Abstract

The Aurora-A kinase gene is amplified in a subset of human tumors and in radiation-induced lymphomas from p53 heterozygous mice. Normal tissues from p53-/- mice have increased Aurora-A protein levels, but lymphomas from these mice exhibit heterozygous deletions of Aurora-A and/or reduced protein expression. A similar correlation between low p53 levels and Aurora-A gene deletions and expression is found in human breast cancer cell lines. In vitro studies using mouse embryo fibroblasts demonstrate that inhibition of Aurora-A can have either positive or negative effects on cell growth as a function of p53 status. These data have implications for the design of approaches to targeted cancer therapy involving the crosstalk between Aurora-A kinase and p53 pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292827      PMCID: PMC2730519          DOI: 10.1016/j.ccr.2006.11.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  48 in total

1.  Genomic analysis of regulatory network dynamics reveals large topological changes.

Authors:  Nicholas M Luscombe; M Madan Babu; Haiyuan Yu; Michael Snyder; Sarah A Teichmann; Mark Gerstein
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Evolutionary conservation of motif constituents in the yeast protein interaction network.

Authors:  S Wuchty; Z N Oltvai; A-L Barabási
Journal:  Nat Genet       Date:  2003-09-14       Impact factor: 38.330

Review 3.  Imatinib as a paradigm of targeted therapies.

Authors:  Brian J Druker
Journal:  Adv Cancer Res       Date:  2004       Impact factor: 6.242

Review 4.  Aurora kinases link chromosome segregation and cell division to cancer susceptibility.

Authors:  Patrick Meraldi; Reiko Honda; Erich A Nigg
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

5.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

6.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

Authors:  Hiroshi Katayama; Kaori Sasai; Hidehiko Kawai; Zhi-Min Yuan; Jolanta Bondaruk; Fumio Suzuki; Satoshi Fujii; Ralph B Arlinghaus; Bogdan A Czerniak; Subrata Sen
Journal:  Nat Genet       Date:  2003-12-14       Impact factor: 38.330

8.  Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.

Authors:  Eva Hernando; Zaher Nahlé; Gloria Juan; Elena Diaz-Rodriguez; Miguel Alaminos; Michael Hemann; Loren Michel; Vivek Mittal; William Gerald; Robert Benezra; Scott W Lowe; Carlos Cordon-Cardo
Journal:  Nature       Date:  2004-08-12       Impact factor: 49.962

9.  Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.

Authors:  Ashraful Hoque; Jennifer Carter; Weiya Xia; Mien-Chie Hung; Aysegul A Sahin; Subrata Sen; Scott M Lippman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

10.  Global organization of metabolic fluxes in the bacterium Escherichia coli.

Authors:  E Almaas; B Kovács; T Vicsek; Z N Oltvai; A-L Barabási
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  39 in total

1.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

2.  Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.

Authors:  Gong Yang; Bin Chang; Fan Yang; Xiaoqing Guo; Kathy Qi Cai; Xue Sherry Xiao; Huamin Wang; Subrata Sen; Mien-Chie Hung; Gordon B Mills; Sandy Chang; Asha S Multani; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-04-27       Impact factor: 12.531

3.  The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Authors:  Rebeca A Frum; Yanping Zhang
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

4.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

5.  p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.

Authors:  Chun-Chi Wu; Tsung-Ying Yang; Chang-Tze Ricky Yu; Liem Phan; Cristina Ivan; Anil K Sood; Shih-Lan Hsu; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

6.  Genetic background influences loss of heterozygosity patterns in radiation-induced mouse thymic lymphoma.

Authors:  Michael Hang; Yurong Huang; Antoine M Snijders; Jian-Hua Mao
Journal:  J Nat Sci       Date:  2015

Review 7.  Kinase signaling and targeted therapy for primary myelofibrosis.

Authors:  Qiong Yang; John D Crispino; Qiang Jeremy Wen
Journal:  Exp Hematol       Date:  2016-12-30       Impact factor: 3.084

8.  Aurora-A kinase is essential for bipolar spindle formation and early development.

Authors:  Dale O Cowley; Jaime A Rivera-Pérez; Mark Schliekelman; Yizhou Joseph He; Trudy G Oliver; Lucy Lu; Ryan O'Quinn; E D Salmon; Terry Magnuson; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

9.  Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas.

Authors:  Jonathan W Friedberg; Daruka Mahadevan; Erin Cebula; Daniel Persky; Izidore Lossos; Amit B Agarwal; Jungah Jung; Richard Burack; Xiaofei Zhou; E Jane Leonard; Howard Fingert; Hadi Danaee; Steven H Bernstein
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

Review 10.  Cell cycle-dependent ciliogenesis and cancer.

Authors:  Olga V Plotnikova; Erica A Golemis; Elena N Pugacheva
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.